Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy Meeting Abstract


Authors: Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
Abstract Title: Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy
Meeting Title: 38th Annual Meeting of the American Society of Hematology
Journal Title: Blood
Volume: 88
Issue: 10 Suppl. 1 Pt. 1
Meeting Dates: 1996 Dec 6-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1996-11-15
Start Page: 481a
Language: English
ACCESSION: WOS:A1996VT98301911
PROVIDER: wos
PUBMED: 8939071
Notes: Meeting Abstract: 1911 -- Source: Wos
MSK Authors
  1. Ariela Noy
    204 Noy
  2. David Golde
    101 Golde
  3. Andrew D Zelenetz
    547 Zelenetz
  4. Peter Maslak
    166 Maslak
  5. Mark Weiss
    80 Weiss